Literature DB >> 26670114

Extending the golden hour: Partial resuscitative endovascular balloon occlusion of the aorta in a highly lethal swine liver injury model.

Rachel M Russo1, Timothy K Williams, John Kevin Grayson, Christopher M Lamb, Jeremy W Cannon, Nathan F Clement, Joseph M Galante, Lucas P Neff.   

Abstract

BACKGROUND: Combat-injured patients may require rapid and sustained support during transport; however, the prolonged aortic occlusion produced by conventional resuscitative endovascular balloon occlusion of the aorta (REBOA) may lead to substantial morbidity. Partial REBOA (P-REBOA) may permit longer periods of occlusion by allowing some degree of distal perfusion. However, the ability of this procedure to limit exsanguination is unclear. We evaluated the impact of P-REBOA on immediate survival and ongoing hemorrhage in a highly lethal swine liver injury model.
METHODS: Fifteen Yorkshire-cross swine were anesthetized, instrumented, splenectomized, and subjected to rapid 10% total blood loss followed by 30% liver amputation. Coagulopathy was created through colloid hemodilution. Randomized swine received no intervention (control), P-REBOA, or complete REBOA (C-REBOA). Central mean arterial pressure (cMAP), carotid blood flow, and blood loss were recorded. Balloons remained inflated in the P-REBOA and C-REBOA groups for 90 minutes followed by graded deflation. The study ended at 180 minutes from onset of hemorrhage or death of the animal. Survival analysis was performed, and data were analyzed using repeated-measures analysis of variance with post hoc pairwise comparisons.
RESULTS: Mean survival times in the control, P-REBOA, and C-REBOA groups were, 25 ± 21, 86 ± 40, and 163 ± 20 minutes, respectively (p < 0.001). Blood loss was greater in the P-REBOA group than the C-REBOA or control groups, but this difference was not significant (4,722 ± 224, 3,834 ± 319, 3,818 ± 37 mL, respectively, p = 0.10). P-REBOA resulted in maintenance of near-baseline carotid blood flow and cMAP, while C-REBOA generated extreme cMAP and prolonged supraphysiologic carotid blood flow. Both experimental groups experienced profound decreases in cMAP following balloon deflation.
CONCLUSION: In the setting of severe ongoing hemorrhage, P-REBOA increased survival time beyond the golden hour while maintaining cMAP and carotid flow at physiologic levels.

Entities:  

Mesh:

Year:  2016        PMID: 26670114     DOI: 10.1097/TA.0000000000000940

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  29 in total

1.  The effect of resuscitative endovascular balloon occlusion of the aorta, partial aortic occlusion and aggressive blood transfusion on traumatic brain injury in a swine multiple injuries model.

Authors:  M Austin Johnson; Timothy K Williams; Sarah-Ashley E Ferencz; Anders J Davidson; Rachel M Russo; William T O'Brien; Joseph M Galante; J Kevin Grayson; Lucas P Neff
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

2.  Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Kiril Chtraklin; Panpan Chang; Nathan J Graham; Basil M Baccouche; Shalini Roy; Mohammed Harajli; Jing Zhou; Vahagn C Nikolian; Qiufang Deng; Yuzi Tian; Baoling Liu; Yongqing Li; Gregory L Hays; Julia L Hays; Hasan B Alam
Journal:  J Vis Exp       Date:  2018-08-24       Impact factor: 1.355

3.  Distal pressure monitoring and titration with percent balloon volume: feasible management of partial resuscitative endovascular balloon occlusion of the aorta (P-REBOA).

Authors:  Yosuke Matsumura; Akiko Higashi; Yoshimitsu Izawa; Shuji Hishikawa; Hiroshi Kondo; Viktor Reva; Shigeto Oda; Junichi Matsumoto
Journal:  Eur J Trauma Emerg Surg       Date:  2019-11-06       Impact factor: 3.693

4.  Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.

Authors:  Mitchell R Dyer; DaShawn Hickman; Norman Luc; Shannon Haldeman; Patricia Loughran; Christa Pawlowski; Anirban Sen Gupta; Matthew D Neal
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

Review 5.  Emerging Endovascular Therapies for Non-Compressible Torso Hemorrhage.

Authors:  Rachel M Russo; Lucas P Neff; Michael Austin Johnson; Timothy K Williams
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

6.  Automated variable aortic control versus complete aortic occlusion in a swine model of hemorrhage.

Authors:  Timothy K Williams; Lucas P Neff; Michael Austin Johnson; Rachel M Russo; Sarah-Ashley Ferencz; Anders J Davidson; Nathan F Clement; John Kevin Grayson; Todd E Rasmussen
Journal:  J Trauma Acute Care Surg       Date:  2017-04       Impact factor: 3.313

Review 7.  Remote Damage Control Resuscitation in Austere Environments.

Authors:  Ronald Chang; Brian J Eastridge; John B Holcomb
Journal:  Wilderness Environ Med       Date:  2017-06       Impact factor: 1.518

8.  Traumatic brain injury may worsen clinical outcomes after prolonged partial resuscitative endovascular balloon occlusion of the aorta in severe hemorrhagic shock model.

Authors:  Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Nathan J Graham; Vahagn C Nikolian; Kiril Chtraklin; Panpan Chang; Jing Zhou; Ben E Biesterveld; Jonathan Eliason; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2019-03       Impact factor: 3.313

9.  Use of Resuscitative Endovascular Balloon Occlusion of the Aorta for Proximal Aortic Control in Patients With Severe Hemorrhage and Arrest.

Authors:  Megan Brenner; William Teeter; Melanie Hoehn; Jason Pasley; Peter Hu; Shiming Yang; Anna Romagnoli; Jose Diaz; Deborah Stein; Thomas Scalea
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

10.  Non-invasive Dual-Channel Broadband Diffuse Optical Spectroscopy of Massive Hemorrhage and Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in Swine.

Authors:  Jesse H Lam; Thomas D O'Sullivan; Tim S Park; Jae H Choi; Robert V Warren; Wen-Pin Chen; Christine E McLaren; Leopoldo C Cancio; Andriy I Batchinsky; Bruce J Tromberg
Journal:  Mil Med       Date:  2018-03-01       Impact factor: 1.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.